Starr, Michelle C.
Schmicker, Robert H.
Halloran, Brian A.
Heagerty, Patrick
Brophy, Patrick
Goldstein, Stuart L.
Juul, Sandra E.
Hingorani, Sangeeta
Askenazi, David J.
,
Article History
Received: 30 August 2022
Revised: 22 December 2022
Accepted: 21 January 2023
First Online: 9 February 2023
Competing interests
: All authors report no real or perceived conflicts of interest that could affect the study design; collection, analysis and interpretation of data; the writing of the report; or the decision to submit the manuscript for publication. For full disclosure, we provide the additional list of authors’ other commitments and funding sources that are not directly related to this study. R.H.S. receives grant funding for studies not related to this project from NHLBI and PCORI. S.L.G. reports personal fees from and a position as a consultant to Nuwellis, Renibus, ExThera, Reata and Medtronic Inc. S.L.G. has an equity interest in MediBeacon, Inc. S.L.G. receives grant funding from and serves as a consultant and on a Speaker’s Bureau for Baxter Healthcare, Inc. S.L.G. receives grant funding and serves as a consultant for BioPorto Diagnostics, Inc. S.L.G. serves on a Speaker’s Bureau for Fresenius Medical Corporation. D.J.A. consults for Baxter, Nuwellis, Medtronic, Bioporto and Seastar Medical. He also receives grant funding for studies not related to this project from Baxter, Nuwellis, Medtronic, SeaStar Medical, Bioporto, and National Institutes of Health (R01 FD005092, U34 KD117128). He is founder and Chief Scientific Officer for Zorro-Flow Inc. He has patents pending for urine collection device and System for Continuous Renal Replacement System.
: Caregiver consent was required for participation in primary (PENUT) study.